The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Hendrik Ungefroren^*, Björn Konukiewitz, Ulrich F. Wellner, Jörg Schrader, Tobias Keck

^*Korrespondierende/r Autor/-in für diese Arbeit

Strategische Forschungsbereiche und Zentren

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

@article{fcdc2d8b29b441f3b67c945b118f65c3,

title = "The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses",

author = "Hendrik Ungefroren and Bj{\"o}rn Konukiewitz and Wellner, {Ulrich F.} and J{\"o}rg Schrader and Tobias Keck",

year = "2023",

month = jan,

doi = "10.3390/cancers15010160",

language = "English",

volume = "15",

journal = "Cancers",

issn = "2072-6694",

number = "1",

}

TY - JOUR

T1 - The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

AU - Ungefroren, Hendrik

AU - Konukiewitz, Björn

AU - Wellner, Ulrich F.

AU - Schrader, Jörg

AU - Keck, Tobias

PY - 2023/1

Y1 - 2023/1

UR - http://www.scopus.com/inward/record.url?scp=85145929498&partnerID=8YFLogxK

U2 - 10.3390/cancers15010160

DO - 10.3390/cancers15010160

M3 - Editorial

AN - SCOPUS:85145929498

SN - 2072-6694

VL - 15

JO - Cancers

JF - Cancers

IS - 1

M1 - 160

ER -